Skip to content
搜索以了解InterSystems产品和解决方案,职业机会等。

FHIR-Powered Analytics and Insights Help Improve Hepatitis C Care Across New Mexico

ROI and a Healthier Population

Woman lab tech at monitor with sample container

CUSTOMER: Rhodes Group

CHALLENGE: Identify Hepatitis C virus (HCV) infections for early treatment in a siloed healthcare environment

OUTCOME: The Rhodes Group HCV algorithm and communications using InterSystems HealthShare helps New Mexico managed care organizations avoid millions of dollars in penalties for missing HCV treatment targets

The Hepatitis C virus (HCV) is known as the silent killer, as people may not notice effects of the infection until the liver has suffered irrevocable damage. Since 2012, Hepatitis C infections have accounted for more deaths in the US than all other infectious diseases combined. In 2013, for example, there were 19,368 HCV-related deaths vs 17,915 for all other nationally notifiable infectious conditions1. Early identification is the key to successful treatment, but how do you identify HCV-positive patients in a siloed healthcare environment?

New Mexico Has a Plan

New Mexico is one of the five states in the US with the highest HCV infection rates. Given the high social and economic burden of the disease – a liver transplant costs about $250,000 with recovery taking roughly a year – New Mexico created a standardized program to catalyze the process of patient identification and treatment. It includes an HCV checklist for providers, to ensure uniform treatment patterns, a promise of full payment for patients on Medicaid, and automated HCV surveillance. The goal is to wipe out the disease in the state by 2030.

Rhodes Group Develops a Solution

New Mexico turned to its statewide health information exchange (HIE), SYNCRONYS, with its large data set, as the starting point to identify Hepatitis C cohorts in its population. But SYNCRONYS was unable to deliver the necessary analytics on its own. Instead, the state approached five software vendors, including Rhodes Group, with the challenge of creating a working proof of concept for

  • Automated identification of HCV positive patients across the state
  • Right-time communication of Hepatitis C status to clinicians, including the comprehensive laboratory results and medication data required for the HCV checklist

Rhodes Group, an information technology company in New Mexico, welcomed this challenge due to their innovative algorithms that interpret laboratory results. Rhodes Group was the only vendor to deliver a working prototype on time, and without increasing the processing burden on the HIE. Rhodes was ultimately awarded the contract for further development. “A lot of this success was because of the nimbleness and malleability of InterSystems HealthShare, its connectivity and all its tools that allow our algorithm to run,” added Rick VanNess, Director of Product Development.

HealthShare and FHIR Deliver When Data and Analytics are Required

The Rhodes Group had performed a similar effort for TriCore, a regional clinical laboratory. TriCore has 11 test codes specific to Hepatitis C. But the SYNCRONYS HIE had nearly all of New Mexico’s laboratory results, from 26 labs, using different codes, different reference ranges, and different standards. “We needed something really robust to look at the data, translate it, and allow our algorithm to function in a secure fashion,” VanNess said, “as well as to return the results back to the HIE for use by clinicians.” When Rhodes Group ran into roadblocks getting access to the required lab data, the company turned to HL7® FHIR® (Fast Healthcare Interoperability Resources). FHIR allowed Rhodes Group to obtain discrete laboratory and clinical data in SYNCRONYS rapidly and transfer it to the HealthShare Unified Care Record. HealthShare normalizes the data and delivers it to the Rhodes Group Hepatitis C identification algorithm, running in the HealthShare Health Insight analytics platform.

Rick VanNess, Director of Product Development, Rhodes Group

Algorithm and Analytics Turn Data Into Action

The Rhodes Group algorithm looks at lab history, at the current lab data for screening, and at the aggregated medical record in the HIE for diagnoses and treatments related to Hepatitis C, and to determine 12-week sustained virologic response (SRV), indicating a cure. “We calculate APRI [aspartate aminotransferase to platelet ratio index] and FIB [an assessment of liver fibrosis] scores to help doctors determine liver health, and we look for other conditions likely to put the patient at risk for complications,” VanNess said. “We also make sure that the pan genotypic drug a patient receives for treatment is the correct one.”

If the algorithm determines a diagnosis of Hepatitis C virus for a patient, or that a patient should be screened for Hepatitis C virus, it inserts a prominent HTML link into the SYNCRONYS medical record. When that link is clicked, the Rhodes Group solution again uses HL7 FHIR to deliver a Hepatitis C summary with the algorithm’s findings to the clinician. The summary includes the aggregated laboratory results data required for completing the uniform HCV checklist to increase the efficiency among clinicians.

When first deployed, the Rhodes Group algorithm identified about 11,700 people with Hepatitis C infections using TriCore Reference laboratory data, and an additional 22,600 people in the HIE data. In total, the data covered about 80% of New Mexico’s population.

ROI and a Healthier Population

At the beginning of the project, the Rhodes Group needed to select a foundational solution, and recommended HealthShare to the HIE. “We had to tell them that we needed the robustness of HealthShare to make our algorithms work,” VanNess said. “We needed HealthShare connectivity and its ability to make FHIR data accessible with the SQL queries our algorithm used.” This clinical analytics system is aimed at returning a tangible ROI for the state in their efforts to eliminate HCV by 2030 by monitoring managed care organizations’ (MCO) contract performance pertaining to the treatment of hepatitis C. New Mexico Health and Human Services implemented Delivery System Improvement Targets among each MCO, one of which requires treating a specific number of beneficiaries with hepatitis C and has a total of $14,299,439 in penalties associated with it. Together, Rhodes and SYNCRONYS provide a tool that enables a near real-time identification of compliance with this measure.

Care Improvements Beyond Hepatitis C

Rhodes Group has achieved similar care and economic results for payers looking at other conditions. For example, by combining the Rhodes Group algorithms for diabetes and prenatal care/pre-term birth for one MCO, the savings amount to $13,527,000. “Specific to risk adjustment,” VanNess added, “we helped a payer by showing them that there are a lot more conditions among its members than they knew of. The value of doing that is roughly an extra payment that can be collected in risk adjustment per member per month per year.”


1 - Oxford Academic, Clinical Infectious Diseases, March 1, 2016. https://academic.oup.com/cid/article/62/10/1287/2462772


您可能喜欢的其他成功案例

数字化转型
作为日本最大的化妆品、日用品和非处方药批发商,PALTAC在将5万件商品从1000家制造商运送到400家零售商、5万家商店的过程中发挥着不可或缺的作用。长期以来,PALTAC一直专注于内部开发工作(占其所有信息系统的70%),以使其供应链能力具备竞争优势。
CurrentCare 基于 InterSystems HealthShare®,与 46 个数据共享合作伙伴相连,从 13 个不同的电子健康档案(EHR)系统中获取信息。
InterSystems 和英国国家卫生服务体系(NHS)领先的移动咨询平台 eConsult 之间的合作,正在改善初级、急诊和门诊护理的提供和效率。
利用 InterSystems IRIS 医疗版实现的一场数字化医疗转型
中东的一家私立医院集团正在把医院带到患者家中。医疗照护团队使用家庭设备对患者进行监测,并通过手机应用程序将设备和患者生成的数据发送到EMR。通过使用熟悉的软件,进行虚拟出诊的医生和护士可以获得所需的全部信息,从而提供最佳的个性化照护。
厦门大学附属翔安医院(以下简称“翔安医院”)是由厦门市政府与厦门大学按照三级甲等医院标准共同出资建设的一所非营利性公立医院。作为厦门大学唯一的直属附属医院,翔安医院以“国内一流、国际知名”为目标,按照三级甲等医院标准建设成为一所集医疗、教学、科研、预防为一体的综合性临床研究型医院。
四则来自 InterSystems HealthShare Health Connect 客户的故事分享
在美国各地,当需要实现大规模的应用集成时,医疗行业的领导者会使用InterSystems HealthShare Health Connect®。
美国西海岸一家大型医疗计划的首席医疗官要求对任何时候谁在医院的情况有完全的了解。 鉴于该医疗计划在InterSystems和健康信息交换(HIE)方面所做的工作,企业数据和分析总监自信地回答:"是的,我们可以做到。""你们能在六个月内做到吗?"CMO问。 答复是什么? 也是肯定的。
成立于2006年的北京美中宜和妇儿医疗集团,致力于创建国际品质的妇儿高端医疗品牌,为中国家庭提供高品质的妇科、产科和儿科等7大服务。经过14年的发展,美中宜和已经成为全国知名的高端私立妇儿医疗集团,并全面开创了一种崭新的国际医疗服务模式。医院参照国际医院管理标准,制定了一套包含 32 个管理模块,1008 条管理制度的医院管理体系,以系统化的模式管理医院,客观地对医疗质量和服务质量进行监测和监督,并持续改进。
现代影像中心利用多种先进技术为患者提供前沿的诊断服务。然而,实现这些系统之间的数据共享却困难重重,这不仅使工作流程变得复杂、护理效率低下,也使得全面分析患者和医疗过程信息变得更加困难。此外,由此而产生的数据量呈指数级增长,让问题变得更加棘手。